FDA Drug Application (208065) for TAGRISSO by ASTRAZENECA PHARMS

Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Application Number208065
Product Number001
FormTABLET;ORAL
DosageEQ 40MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTAGRISSO
Active IngredientOSIMERTINIB MESYLATE



Back to FDA Applications sponsored by ASTRAZENECA PHARMS